The unfolded protein response (UPR) is activated by endoplasmic reticulum stress resulting from an accumulation of unfolded or mis-folded proteins. The UPR is divided into three arms, involving the activation of ATF-6, PERK and IRE-1, that together act to restrict new protein synthesis and increase the production of chaperones. Recent studies have implicated the PERK and IRE-1 components of the UPR in adipocyte differentiation. In this study, we investigate the importance of ATF6a during adipogenesis using stable knockdown of this protein in the model adipogenic cell line, C3H10T1/2. Reduction of ATF6a expression by 470% resulted in impaired expression of key adipogenic genes and reduced lipid accumulation following the induction of adipogenesis. In contrast, loss of ATF6a did not impair the ability of cells to undergo osteogenic differentiation. Overall, our data indicate that all three arms of the UPR, including ATF6a, must be intact to permit adipogenesis to occur.
INTRODUCTION
Adipose tissue dysfunction is proposed to contribute significantly to obesity-related metabolic disease. 1 Consequently, understanding the molecular basis of adipogenesis may provide therapeutic approaches to improve adipose function and the pathophysiology of obesity. Adipose tissue is not only the predominant site of lipid storage but also functions as an important nutrient sensing and endocrine organ. 2 The endoplasmic reticulum (ER) is a major site for protein and lipid synthesis, and in states of overnutrition elevated levels of ER stress have been reported. 3 The unfolded protein response (UPR) to cellular stress is activated by the accumulation of unfolded proteins in the ER. The UPR involves three distinct pathways initiated by the activation of the ER membrane kinase PERK, the non-conventional mRNA splicing enzyme IRE-1 and the transcription factor ATF6a. These pathways work together to re-establish cellular homeostasis. Broadly, the PERK and IRE-1 pathways reduce the translation of new proteins, whereas the IRE-1 and ATF6a pathways increase the capacity of the ER to process the accumulated unfolded proteins. 4 The importance of the UPR has been demonstrated in highly secretory cells, such as pancreatic b cells 5 and plasma B cells, which exhibit elevated levels of the UPR and in B-cells this is essential for terminal differentiation. 6 Several studies link ER stress with the pathophysiology of obesity. 7, 8 However, given the high secretory capacity and metabolic activity of adipocytes, the involvement of the UPR in normal adipocyte development has also recently been investigated. This has revealed that a physiological level of the UPR may be required for adipogenesis to occur. Specifically, PERKdeficient mouse embryonic fibroblasts and 3T3-L1 preadipocyte cells display reduced adipogenic capacity, reduced expression of lipogenic genes and impaired lipid accumulation. 9 A detailed study of the IRE-1 arm of the UPR revealed that this too has an important role in adipogenesis. Expression of mRNA encoding an inactive form of the transcription factor XBP-1 (XBP-1u) is induced by C/EBPb during early adipogenesis. Upon activation of the UPR, XBP-1u mRNA undergoes non-conventional splicing by IRE-1 to generate an mRNA encoding the active XBP-1 protein (XBP-1s). In turn XBP-1s binds to and activates the promoter of the critical adipogenic transcription factor C/EBPa. Thus, loss of either XBP-1 or IRE-1 in mouse embryonic fibroblasts or 3T3-L1s results in impaired adipogenesis.
10
ATF6a is a transmembrane protein that, following activation of the UPR, undergoes proteolytic cleavage by site-specific proteases to produce a free 50 kDa active transcription factor, which upregulates the expression of ER chaperones. 4 As both the PERK and IRE-1 arms of the UPR have key roles in adipocyte differentiation, we investigated whether this third arm, involving ATF6a, is also required for adipogenesis.
RESULTS AND DISCUSSION
To determine the relative expression of ATF6a in adipose tissue, the levels of ATF6a mRNA were determined in a murine tissue panel ( Figure 1a ). As might be expected given the ubiquitous nature of the UPR, this revealed detectable levels of ATF6a mRNA in all tissues tested, including abundant expression in mesenteric, subcutaneous and brown adipose tissue. We next examined ATF6a mRNA expression in C3H10T1/2 mesenchymal stem cells following induction of adipogenesis using medium containing fetal bovine serum supplemented with insulin, dexamethasone and IBMX (IDM), as described previously.
11 ATF6a mRNA was detected at all time points but did not significantly change as adipogenesis proceeded (Figure 1b) . We also determined the expression of ATF6a (p90) protein during adipogenesis in these cells. This revealed a modest increase in ATF6a during the first 5 days of adipogenesis (Figure 1c) , which subsequently decreased to undetectable levels at D8 (Figure 1c) . The available antibodies were unable to detect the 50 kDa active form of ATF6a (p50). Thus, we are unable to specifically analyse the proteolytic activation of ATF6a during adipogenesis. However, these data demonstrate that ATF6a protein is expressed in these cells and regulated during adipogenesis.
To examine the importance of ATF6a in adipogenesis, we used shRNA to stably inhibit ATF6a expression in C3H10T1/2 cells. Briefly, two shRNA sequences targeting ATF6a (shATF6a-1; exon 1--2; 5 0 -AAGACTGGGAGTCGACGTTGT-3 0 and shATF6a-2; exon 4 --5; 5 0 -AACTCAGCACGTTCCTGAGGA-3 0 ) were designed and cloned into RNAi-ready pSIREN---RetroQ vector (Clontech, Mountain View, CA, USA). Retroviruses were produced by transfecting ATF6a shRNA constructs or a control shRNA vector into BOSC-HEK293 packaging cells. These were used to infect C3H10T1/2 cells, as previously described, 11 generating two ATF6a knockdown cell lines. Analysis of the shATF6a expressing cell lines indicated ATF6a mRNA expression was reduced by more than 70% in both cell lines when compared with the control cells across a time course of adipogenesis (Figure 2a) . A second isoform of ATF6, ATF6b is highly homologous to ATF6a with a proposed inhibitory role on ATF6a targets. 12 We therefore tested whether the ATF6a shRNA affected ATF6b mRNA expression. No significant difference was seen in ATF6b expression levels in cells expressing either ATF6a shRNA when compared with control cells, indicating that both shRNA are specific to ATF6a (Figure 2b ). Western blot analysis verified that ATF6a protein levels, were also inhibited by shATF6a-1 and shATF6a-2, respectively, in D0 cells (Figure 2c) .
We next examined the effect of ATF6a knockdown of the expression of key adipogenic genes during differentiation. Following induction of adipogenesis with IDM medium, control and ATF6a knockdown cell lines displayed similar increases in the expression of the early adipogenic transcription factor, C/EBPb (Figure 2d) . However, the degree of induction was modestly, but significantly, reduced by ATF6a knockdown. The induction of the adipogenic transcription factor PPARg was modestly, but significantly, reduced in ATF6a knockdown cells at early time points up to day 3 and more markedly impaired as adipogenesis proceeded (Figure 2e ). In addition, expression of the lipogenic transcription factor SREBP1c, the insulin-sensitive glucose transporter, GLUT4 and fatty acid-binding protein, aP2, all exhibited dramatically reduced levels of mRNA expression in the ATF6a knockdown cells (Figures 2f --h) . Western blotting of aP2 expression demonstrated that this was not induced following adipogenic treatment of ATF6a knockdown cells, consistent with the mRNA expression data (Figure 2i) . Overall, these data demonstrate that, at least in this cellular model of adipogenesis, ATF6a expression is required for the normal induction of adipogenic gene expression. Samples were sonicated and 20 mg subjected to western blotting using antibodies against ATF6a (ab11909, Abcam, Cambridge, UK). Images were quantified using NIH Image J software (http://rsbweb.nih.gov/ij/) and ATF6a intensity normalised to calnexin, n ¼ 3, ± s.e.m., * indicates significance of Po0.05 with respect to levels in undifferentiated cells. Representative western blots of ATF6, the adipocyte marker aP2 and the loading control calnexin (ab13504, Abcam) are shown from the same lysate samples.
Consistent with the impaired expression of these genes lipid accumulation, as measured by Oil red O staining, 13 was markedly reduced in the ATF6a-deficient cells (Figure 2j, upper panels) . To ensure that this did not reflect a non-specific defect in cells lacking ATF6a, these cells were also treated with osteogenic induction medium. After 5 days of differentiation alkaline phosphatase activity, a marker of osteogenesis, was visualised with BCIP/NBT. This revealed that the osteogenic capacity of these cells was not impaired by ATF6a knockdown (Figure 2j , lower panels). Thus, ATF6a appears selectively important for adipocyte differentiation.
In conclusion, we have demonstrated that knockdown of ATF6a significantly, and selectively, impairs the ability of C3H10T1/2 cells to differentiate into mature adipocytes. Further study is required to determine the precise mechanisms involved, and to determine whether this is also the case in other cellular and in vivo models of adipocyte development. However, coupled to the previous studies of PERK and IRE-1, these data suggest that all three arms of the UPR must be intact to permit adipogenesis to occur.
